欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IE/H/1270/001
药品名称Teicoplanin Seacross 200 mg powder for solution for injection/infusion or oral solution
活性成分
    • Teicoplanin 200.0 mg
剂型Solution for injection
上市许可持有人Seacross Pharma (Europe) Limited, Pod 13, The Old Station House, 15a Main Street, Blackrock, Dublin, A94 T8P8, Ireland
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • Portugal (PT)
    • Italy (IT)
    • Germany (DE)
      Teicoplanin Seacross 200 mg Pulver zur Herstellung einer Injektions-/Infusionslösung oder einer Lösung zum Einnehmen
    • Netherlands (NL)
    • France (FR)
许可日期2024/12/10
最近更新日期2024/12/11
药物ATC编码
    • J01XA02 teicoplanin
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase